Skip to main content
Kukje Pharma Co., Ltd. logo

Kukje Pharma Co., Ltd. — Investor Relations & Filings

Ticker · 002720 ISIN · KR7002720001 KO Manufacturing
Filings indexed 297 across all filing types
Latest filing 2022-08-16 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 002720

About Kukje Pharma Co., Ltd.

https://www.kukjepharm.co.kr/index.php?…

Kukje Pharma Co., Ltd. is a company engaged in the manufacturing, distribution, import, and export of pharmaceutical products, cosmetics, and health supplements. Its core offerings include a wide range of prescription (ETC) and over-the-counter (OTC) drugs, with a notable specialization in antibiotics such as Cephalosporins. In addition to its primary pharmaceutical business, the company also develops and markets cosmetic products, food supplements, and respiratory protection face masks. The company serves both domestic and international markets.

Recent filings

Filing Released Lang Actions
반기보고서 (2022.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for Kukje Pharma Co., Ltd., covering the period from January 1, 2022, to June 30, 2022. It contains detailed financial information, business operations, management discussions, and corporate governance data. As it is a comprehensive financial report for a period shorter than a full fiscal year (half-year) and includes substantive financial data, it is classified as an Interim/Quarterly Report. H1 2022
2022-08-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (specifically a purchase) by a company executive (Jung Hyun-soo) of Kukje Pharma. This type of filing is a standard regulatory requirement for reporting insider trading or changes in share ownership by company directors/executives, which corresponds to the 'Director's Dealing' category.
2022-07-01 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (specifically '장내매수' or open market purchase) by an executive (Choi Hae-sung) of Kukje Pharma. This type of filing is a standard regulatory requirement for insider trading/shareholding disclosures, which corresponds to the 'Director's Dealing' category.
2022-07-01 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details a transaction (purchase of 2,000 shares) by an executive (Park Hyun-sam) of Kukje Pharma. This is a standard regulatory filing for insider trading/director dealings in the Korean market.
2022-07-01 Korean
최대주주등소유주식변동신고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders and Others' (최대주주등소유주식변동신고서) for the company Kukje Pharma. It details specific share transactions by company executives (e.g., Park Hyun-sam) and provides a comprehensive table of share ownership for major shareholders and related parties. This falls under the category of 'Director's Dealing' as it reports personal share transactions by company directors/executives and changes in major shareholdings.
2022-07-01 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in shareholding, and collateral agreements of major shareholders. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2022-06-15 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.